Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigation

Transarterial Radioembolization in the TACOME Trial: Dosimetric Analysis and Clinical Features in Predicting Response and Overall Survival

Cigdem Soydal, Mine Araz, Burak Demir, Tunc Ones, Kerim Sonmezoglu, Nalan Alan Selcuk, Tugsan Balli, Emine Goknur Isık, Bilge Volkan Salancı, Erkan Derebek, Selin Kesim, Onur Erdem Sahin, Ferhat Can Piskin, Emre Can Celebioglu, Mehmet Sadik Bilgic and Nuriye Ozlem Kucuk
Journal of Nuclear Medicine May 2025, jnumed.125.269519; DOI: https://doi.org/10.2967/jnumed.125.269519
Cigdem Soydal
1Department of Nuclear Medicine, Ankara University Medical School, Ankara, Turkey;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mine Araz
1Department of Nuclear Medicine, Ankara University Medical School, Ankara, Turkey;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Burak Demir
1Department of Nuclear Medicine, Ankara University Medical School, Ankara, Turkey;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tunc Ones
2Department of Nuclear Medicine, Marmara University Medical School, Istanbul, Turkey;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kerim Sonmezoglu
3Department of Nuclear Medicine, Istanbul University Cerrahpasa Medical School, Istanbul, Turkey;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nalan Alan Selcuk
4Department of Nuclear Medicine, Yeditepe University Medical School, Istanbul, Turkey;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tugsan Balli
5Department of Radiology, Cukurova University Medical School, Adana, Turkey;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emine Goknur Isık
6Department of Nuclear Medicine, Istanbul University Capa Medical School, Istanbul, Turkey;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bilge Volkan Salancı
7Department of Nuclear Medicine, Hacettepe University Medical School, Ankara, Turkey;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erkan Derebek
8Department of Nuclear Medicine, Dokuz Eylul University Medical School, Izmir, Turkey; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Selin Kesim
2Department of Nuclear Medicine, Marmara University Medical School, Istanbul, Turkey;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Onur Erdem Sahin
3Department of Nuclear Medicine, Istanbul University Cerrahpasa Medical School, Istanbul, Turkey;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ferhat Can Piskin
5Department of Radiology, Cukurova University Medical School, Adana, Turkey;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emre Can Celebioglu
9Department of Radiology, Ankara University Medical School, Ankara, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mehmet Sadik Bilgic
9Department of Radiology, Ankara University Medical School, Ankara, Turkey
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nuriye Ozlem Kucuk
1Department of Nuclear Medicine, Ankara University Medical School, Ankara, Turkey;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Visual Abstract

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Abstract

In this multicenter retrospective study, we aimed to analyze the dose–response and survival relationships and estimate the tumor absorbed radiation dose required to achieve response in colorectal cancer liver metastases treated with 90Y glass microspheres. Methods: Patients with metastatic colorectal cancer treated with 90Y glass microspheres were included in this retrospective study. Mean perfused volume, mean estimated perfused volume absorbed dose, mean estimated tumor absorbed dose (ETAD), mean estimated perfused normal liver absorbed dose, and mean estimated whole liver absorbed dose were calculated using [99mTc]-macroaggregated albumin SPECT images. Treatment to response was evaluated by [18F]-FDG PET images. Results: In total, 176 patients (112 men and 64 women) were included in the analysis. A strong correlation was found between mean ETAD and response to treatment (P = 0.001). The cutoff values to predict a response were calculated as 109 Gy (sensitivity, 68%; specificity, 73%; area under the curve, 0.728; P = 0.001) for mean estimated perfused volume absorbed dose and 152 Gy (sensitivity, 93%; specificity, 89%; area under the curve, 0.945; P = 0.001) for mean ETAD. The median overall survival (OS) of patients with a mean ETAD higher than 152 Gy was significantly longer than that of the remaining patients, at 18.1 mo (95% CI, 15.7–20.4 mo) versus 12.8 mo (95% CI, 10.6–15.0 mo; P = 0.030). Further analysis using maximally selected rank statistics to better predict OS showed that patients with a minimum mean ETAD of 203 Gy had OS 6.4 mo longer than the OS of those with a lower mean ETAD (P = 0.022). Conclusion: A mean radiation dose to the tumor of at least 152 Gy may predict a metabolic response. Although a threshold of 152 Gy predicted longer OS, a mean ETAD of 203 Gy, when achievable, predicted even longer OS than found for those with a mean ETAD of less than 203 Gy.

  • colorectal cancer liver metastasis
  • transarterial radioembolization
  • 90Y glass microspheres
  • multicompartment dosimetry
  • response to treatment

Footnotes

  • Published online May 22, 2025.

  • © 2025 by the Society of Nuclear Medicine and Molecular Imaging.
View Full Text

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

SNMMI members

SNMMI Member Login

Login to the site using your SNMMI member credentials

Individuals

Non-Member Login

Login as an individual user

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 66 (5)
Journal of Nuclear Medicine
Vol. 66, Issue 5
May 1, 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Transarterial Radioembolization in the TACOME Trial: Dosimetric Analysis and Clinical Features in Predicting Response and Overall Survival
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Transarterial Radioembolization in the TACOME Trial: Dosimetric Analysis and Clinical Features in Predicting Response and Overall Survival
Cigdem Soydal, Mine Araz, Burak Demir, Tunc Ones, Kerim Sonmezoglu, Nalan Alan Selcuk, Tugsan Balli, Emine Goknur Isık, Bilge Volkan Salancı, Erkan Derebek, Selin Kesim, Onur Erdem Sahin, Ferhat Can Piskin, Emre Can Celebioglu, Mehmet Sadik Bilgic, Nuriye Ozlem Kucuk
Journal of Nuclear Medicine May 2025, jnumed.125.269519; DOI: 10.2967/jnumed.125.269519

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Transarterial Radioembolization in the TACOME Trial: Dosimetric Analysis and Clinical Features in Predicting Response and Overall Survival
Cigdem Soydal, Mine Araz, Burak Demir, Tunc Ones, Kerim Sonmezoglu, Nalan Alan Selcuk, Tugsan Balli, Emine Goknur Isık, Bilge Volkan Salancı, Erkan Derebek, Selin Kesim, Onur Erdem Sahin, Ferhat Can Piskin, Emre Can Celebioglu, Mehmet Sadik Bilgic, Nuriye Ozlem Kucuk
Journal of Nuclear Medicine May 2025, jnumed.125.269519; DOI: 10.2967/jnumed.125.269519
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • ACKNOWLEDGMENTS
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • 177Lu-PSMA-617 Consolidation Therapy After Docetaxel in Patients with Synchronous High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Randomized, Phase 2 Trial
  • Retreatment of Metastatic Castration-Resistant Prostate Cancer Patients with 223Ra Therapy in Daily Practice
Show more Clinical Investigation

Similar Articles

Keywords

  • colorectal cancer liver metastasis
  • transarterial radioembolization
  • 90Y glass microspheres
  • multicompartment dosimetry
  • response to treatment
SNMMI

© 2025 SNMMI

Powered by HighWire